Intrinsic Value
Keros Therapeutics, Inc. (KROS)
$66.2
+1.54 (+2.38%)
Enterprise Value | - |
---|---|
Net Debt | -316.70 |
Equity Value | - |
Shares Outstanding | 29.45 |
Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt